KRMD logo

KORU MEDICAL SYSTEMS INC

KRMDNASDAQ
๐Ÿ† #3215 by market capEarnings Nov 11US Equity
$3.45โ–ฒ $0.05 (+1.47%)
๐ŸŒ… Pre-market$3.45โ–ฒ 0.00%Regular close ยท extended-hours price shown
1hโ€”
24hโ–ฒ 1.5%
7dโ–ผ 16.1%
14dโ–ผ 15.1%
30dโ–ผ 18.5%
1yโ–ผ 16.8%
๐ŸฆMarket Cap
$158M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+22.4%
Healthy
๐Ÿ“ŠGross Margin
62.4%
High
๐Ÿ’ตFCF Margin
1.5%
Thin
โš–๏ธP/S Ratio
3.5x
Fair
Otter Score
59
Weak

Trading Snapshot

Day Range
$3.43 โ€“ $3.51
52-Week Range
$3.21 โ€“ $6.61
Volume
$3.09B
Avg Volume
$3.05B
Shares Outstanding
45.9M
Next Earnings
Oct 3, 2026

Fundamentals Snapshot

Annual Revenue
$41M
Last Q Revenue
$12M
P/E Ratio
โ€”
P/S Ratio
3.5x
EPS (TTM)
$-0.04
Dividend Yield
โ€”

Why Investors Own KRMD

  • โœ“High-growth profile โ€” revenue up +36.3% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 37% gross margin and 21% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$41Mโ–ฒ +42.4% YoY
Gross Margin (TTM)
36.5%โ–ฒ +2.3% YoY
Operating Income (TTM)
$9Mโ–ฒ +42.4% YoY
Free Cash Flow (TTM)
$9Mโ–ฒ +42.4% YoY

About KORU MEDICAL SYSTEMS INC

KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
59/100

Analyst Ratings

โ“˜
Consensus
Buy
11 analysts
Strong Buy2
Buy7
Hold2
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates